maintenance of all 35 patients on daily haloperidol 15 mg , or its neuroleptic equivalent , and small repeated doses of l-dopa induced a stable remission of all involuntary dyskinetic movements for the study year .
C0018546
haloperidol
C0040615
neuroleptic